Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > Issuance of Common Stock

Aerie Pharmaceuticals Issuance of Common Stock Chart (AERI)

Aerie Pharmaceuticals annual/quarterly Issuance of Common Stock from 2012 to 2019.
  • Aerie Pharmaceuticals Issuance of Common Stock for the quarter ending December 12, 2019 was $1m a 64.95% increase of 1m year over year
  • Aerie Pharmaceuticals Issuance of Common Stock for the last 12 months ending June 06, 2020 was $1m a -0.19% decrease of 0m year over year
  • Aerie Pharmaceuticals Annual Issuance of Common Stock for 2019 was $1m a -9,561.04% decrease of -138m from 2018
  • Aerie Pharmaceuticals Annual Issuance of Common Stock for 2018 was $140m a 2.84% increase of 4m from 2017
  • Aerie Pharmaceuticals Annual Issuance of Common Stock for 2017 was $136m a -24.31% decrease of -33m from 2016
Other Cash Flow Metrics:
  • Aerie Pharmaceuticals Cash Flow from Operations for the quarter ending September 09, 2018 was $-43m a 39.56% decrease of -17m year over year
  • Aerie Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-29m a -53.21% increase of 16m year over year
  • Aerie Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $7m
View Chart On Koyfin

Quarterly AERI Issuance of Common Stock Data

12/2019$1m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$1m
09/2018$3m
06/2018$0m
03/2018$136m
12/2017$13m
09/2017$0m

Annual AERI Issuance of Common Stock Data

2019$1m
2018$140m
2017$136m
2016$169m
2015$52m
2014$0m
2013$72m
2012$0m
2011$0m